A Plus Asset Reports Cumulative Operating Profit of 41.1 Billion Won for the First Three Quarters… Up 82% Year-Over-Year
Cumulative Revenue of 580.5 Billion Won and Net Income of 28.8 Billion Won Grow in Tandem
Both Operating Profit and Net Income Exceeded Last Year’s Full-Year Results
[Edaily Reporter Kim Se-yeon ] General Insurance Agency (GA) A Plus Asset(244920)reported an 82% year-over-year increase in cumulative operating profit for the first three quarters of this year. Revenue and net income also posted double-digit growth rates, with the company surpassing last year’s full-year profit in just three quarters. Building on this improved performance, the company is accelerating shareholder returns, including share buybacks and cancellations. (Photo: A Plus Asset) A Plus Asset announced on the 16th that its cumulative consolidated operating profit for the first three quarters of this year reached 41.1 billion won, an 82.4% increase compared to the same period last year. During the same period, revenue rose 15.7% to 580.5 billion won, while net income increased 62.3% to 28.8 billion won. Both operating profit and net income exceeded last year’s full-year figures of 29.3 billion won and 24.7 billion won, respectively. Return on equity (ROE) also improved. As of the end of the third quarter of this year, ROE stood at 19.96%, up 6.90 percentage points from the same period last year (13.06%). A Plus Asset explained that the growth in earnings was driven by the expansion of its high-performing insurance agent organization and improvements in sales efficiency metrics such as agent retention rates, productivity, and policy retention rates. A GA is a corporate insurance agency that enters into contracts with insurance companies to sell products from multiple insurers on their behalf. Since commissions from insurance product sales are the primary source of revenue, factors such as the productivity of the agent force and policy retention rates significantly impact profitability. The company is also responding to reforms in the insurance sales commission system. Ahead of the implementation of a four-year installment system for sales commissions next January, the company stated that it is strengthening its internal control systems and financial soundness management. The company is also expanding shareholder returns. At a board meeting last month, A Plus Asset approved a plan to enhance corporate value and decided to purchase an additional 3.5 billion won worth of treasury stock. The 7 billion won treasury stock purchase decided last July has already been completed. The total amount of treasury stock purchases decided this year amounts to 10.5 billion won, and the company plans to cancel all acquired shares. The company is also moving forward with making A Plus Realty, an unlisted subsidiary, a wholly-owned subsidiary. To increase its current 95.3% stake to 100%, it plans to acquire the minority shareholders’ stakes through a comprehensive stock swap involving a cash payment. The company envisions that this will simplify its corporate governance structure and enhance the efficiency of decision-making and resource allocation. An official from A Plus Asset stated, “This year, alongside external growth, we have devoted company-wide efforts to enhancing our internal control systems and managing financial soundness,” adding, “We will proactively respond to regulatory changes while seamlessly executing our corporate value enhancement plan to increase shareholder value.”
AJU IB INVESTMENT CO., LTD.(027360)posted relatively solid earnings despite an unstable market environment marked by a correction in the KOSDAQ market and exchange rate fluctuations. Although valuatio…
LF achieved both revenue growth and improved profitability in the third quarter, driven by balanced growth across its in-house and imported fashion and beauty brands. LF(093050)According to the quarte…
Boryung(003850)and Celltrion Pharm Inc. will jointly market the “Nesina” and “Actos” product lines for the treatment of type 2 diabetes. The strategy is to expand their presence in the domestic diabet…